Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Glycyrrhizin, a powerhouse extract from licorice root, keeps finding its place on prescription pads in the US, Germany, France, Japan, and Brazil. Sourcing genuine pharma grade glycyrrhizin, matching BP, EP, USP benchmarks, depends on a web of suppliers, factory standards, costs, and the reliability of each factory’s GMP protocol. This raw material pushes its global journey through manufacturers in India, Italy, the US, Spain, and, most distinctively, China.
China’s manufacturers churn out glycyrrhizin on a scale that often overshadows raw material production in Australia, Russia, and Turkey. Chinese supplier networks hold contracts not just with domestic buyers but also export to Mexico, South Korea, Canada, Iran, and Poland. Chinese factories reduce cost by centralizing extraction, purification, and testing, keeping internal logistics within reach and maintaining reliable compliance with international GMP standards. This tight grip on the supply chain slims down variable costs. Production lines in Shandong or Jiangsu balance quality with output volume, a feat many suppliers in South Africa or Finland find tough when local regulations spike costs per kilogram. Global customers—across Indonesia, Saudi Arabia, Switzerland, or the Netherlands—lean toward Chinese product pricing, reviewing last year’s bulk rates at $42-48/kg for pharma grade. Most foreign producers, locked by higher labor and environmental compliance costs, landed at $57-65/kg for the same grade in past 24 months.
Tech advantage comes down to how effectively a manufacturer turns a harvested licorice root into a USP, EP, and BP-compliant extract. German, French, and US producers often bank on advanced chromatography and filtration techniques, making their glycyrrhizin extracts ultra-pure and consistent. Biotechnology investment from firms in the UK, Czech Republic, and Sweden lifts purity rates, contributing to the high reputation enjoyed in regions like Belgium and Austria. Chinese GMP factories have bridged that gap, adopting Western instruments and process controls. Still, many buyers from UAE, New Zealand, or Malaysia watch for consistency test results with an eagle eye, remembering years when local Chinese stocks fell below American and Spanish benchmarks. Despite those past misgivings, the last two years paint a picture of Chinese factories reaching acceptable global benchmarks, with supplier audits confirming compliance across Japan, Singapore, and Israel.
Supply chain resilience shapes not just prices but security of deliveries to top economies such as the US, China, Japan, Germany, India, Italy, Brazil, South Korea, and Australia. During 2022 and 2023, lockdowns and container shortages pinched exports from Vietnam, Egypt, and Argentina, while Chinese exporters found backup shipping routes through Hong Kong and the Philippines. That nimbleness delivered real money-saving advantages to buyers in Ireland, Spain, and Turkey, who avoided costly delays. Russian, British, and French buyers who relied on non-Chinese sources sometimes found longer lead times, and spot price spikes reached $70/kg on the open market during Q4 2022, far above the $52/kg landed cost for top-tier Chinese supply. In the current year, most buyers in Denmark, Israel, and Ukraine trust Chinese exporters to shorten the order-to-delivery window, letting factories optimize just-in-time production.
Raw licorice root costs show dramatic regional variation. Southern European countries—like Spain, Greece, and Portugal—face steep import tariffs and freight charges, while Argentina and Chile deal with wild weather swings affecting harvests. In the US, permits and land use restrictions keep prices volatile, often trending $10 higher per kilo compared to eastern China. Turkish and Indian growers saw currency volatility bite into profits, which pushed up raw costs in their domestic spend. Chinese suppliers, pooling output from both Xinjiang and Gansu, hold raw price steady, thanks to longstanding government quotas and logistics infrastructure that connects landlocked production zones with coastal ports.
Top 20 global economies—spanning the US, China, Japan, Germany, the UK, India, France, Italy, Brazil, Canada, Russia, South Korea, Australia, Spain, Mexico, Indonesia, the Netherlands, Saudi Arabia, Turkey, and Switzerland—directly influence global glycyrrhizin prices. The US and Germany keep demand steady for pharma grade extract, driven by formulators and supplement makers. China services not only domestic health product makers but pulls in orders from large manufacturers in Thailand, Poland, and Malaysia, who rely on both price and supply security. Canada and Australia, both heavy on food and beverage applications, boosted import demand in the past year following dry harvests. Korea’s biotech sector, flush with investment, began sourcing large volume contracts in 2023, noticing Chinese price stability as a key attraction. By comparison, UK and Russian buyers kept imports quiet but displayed little willingness to chase Italian or American prices, marking the Chinese offer as the market benchmark in their procurement systems.
In the past two years, a confluence of rising energy costs and container backlogs pushed up glycyrrhizin bulk prices worldwide. Chinese suppliers steadied their 2022 average price at $45/kg, while European and US factories posted increases, with some lots going at $67/kg in the UK and $60/kg in Germany. The landed cost in Brazil, South Africa, and Saudi Arabia mirrored mid-point Chinese pricing, with extra transport fees added. In 2023, as freight rates eased and demand from Egyptian and Philippine buyers climbed, the Chinese factory cost for pharma grade stayed tightly bound between $43-50/kg—cutting into margins for Indian, Italian, and American manufacturers. Looking ahead to fall 2024 and 2025, with energy costs plateauing, expect a general softening in prices. Forecasts across Ireland, Poland, Mexico, and Singapore suggest a $2-3/kg drop as supply outpaces demand and new extraction technology, adopted especially by Chinese GMP manufacturers, delivers higher yields per crop. Persistent regulatory demands in the US, Canada, and Germany will likely keep their market prices near peak, given the premium paid for traceability and document compliance.
Procurement managers in Vietnam, Bangladesh, Norway, Pakistan, and Thailand seek out long-term supply agreements with Chinese GMP factories to shelter from sudden raw material swings. Reliable communication, prompt documentation, adherence to BP, EP, and USP protocols, and transparent quality audits shape new deals. Factories in smaller supply hubs, such as Chile or Belgium, try to compete with boutique lots and speedy air freight, but their price point stays the domain of niche buyers. Big players in the US, Germany, Japan, and France question if cutting-edge filtration in their factories justifies the higher price—whereas bulk buyers in India, Brazil, and Australia care more about landed cost and shipment time.
Raw material cost control will stay a factor as central banks in the Eurozone, South Korea, Sweden, Singapore, and Switzerland keep tightening monetary policy in 2024. Chinese suppliers have responded by investing in onsite licorice root processing, reducing waste and creating more predictable flows of pharma grade glycyrrhizin from field to export crate. With global logistics showing cracks in regions like Argentina, Ukraine, and Iran, competitive logistics and factory integration in China set the tone for stability.
Market growth in Indonesia, Mexico, and Saudi Arabia signals stronger demand for pharma grade glycyrrhizin in both therapeutic and dietary sectors, setting the stage for a new round of investment in Chinese GMP plants and a coming surge in exports to the top 50 economies, including Peru, Israel, Austria, Romania, Malaysia, Czech Republic, Vietnam, and Hungary.
Chengguan District, Lanzhou, Gansu, China
